Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization

Autores
Gómez Alvis, Alicia; Rebolledo, Alejandro; Milesi, Verónica; Raingo, Jesica; Sanz, Nora; Tommasi, Juan J.; Drago, Adolfo; Rinaldi, Gustavo; Grassi de Gende, Ángela
Año de publicación
2004
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Hemodynamic care during postoperative management of myocardial revascularization should include vasorelaxing drugs to insure adequate graft and coronary flow, and stimulation of stroke volume to maintain vascular perfusion pressure. We tested the cardiac (inotropic and lusitropic) and vascular (relaxant) effects of diltiazem (0.1 nM to 0.1 mM), dobutamine (10 μM to 10 mM) and amrinone (10 μM to 1 mM) on isolated rat atria and thoracic aorta, and also on isolated human saphenous vein (HSV) and human mammary artery (HMA). Dobutamine produced a maximal positive inotropic effect (+dF/dtmax = 29 ± 7%) at its ED50 for aortic relaxation (88 ± 7 μM). Conversely, at their ED50 for aortic relaxation diltiazem depressed myocardial contractility and amrinone did not exhibit myocardial effects. In HSV and HMA contracted with 80 mM potassium, diltiazem and dobutamine (but not amrinone) had a vasorelaxant activity similar to that in rat aorta. Norepinephrine-contracted human vessels were significantly more sensitive than potassium-contracted vessels to the relaxant effect of amrinone (ED50 HMA = 15 ± 5 μM, ED50 HSV = 72 ± 31 μM, P < 0.05). We conclude that at concentrations still devoid of myocardial effects dobutamine and amrinone are effective dilators in graft segment vessels and rat aorta contracted by membrane depolarization. If the difference between aortic and myocardial tissue still holds in human tissues, at the appropriate concentrations these drugs should be expected to improve cardiac performance while still contributing to the maintenance of graft patency.
Facultad de Ciencias Exactas
Materia
Ciencias Exactas
Biología
Amrinona
Dobutamina
Diltiazem
Vena Safena
Arterias Mamarias
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc/3.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/29738

id SEDICI_96ea0021fb8181be85afa2a4653421c2
oai_identifier_str oai:sedici.unlp.edu.ar:10915/29738
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularizationGómez Alvis, AliciaRebolledo, AlejandroMilesi, VerónicaRaingo, JesicaSanz, NoraTommasi, Juan J.Drago, AdolfoRinaldi, GustavoGrassi de Gende, ÁngelaCiencias ExactasBiologíaAmrinonaDobutaminaDiltiazemVena SafenaArterias MamariasHemodynamic care during postoperative management of myocardial revascularization should include vasorelaxing drugs to insure adequate graft and coronary flow, and stimulation of stroke volume to maintain vascular perfusion pressure. We tested the cardiac (inotropic and lusitropic) and vascular (relaxant) effects of diltiazem (0.1 nM to 0.1 mM), dobutamine (10 μM to 10 mM) and amrinone (10 μM to 1 mM) on isolated rat atria and thoracic aorta, and also on isolated human saphenous vein (HSV) and human mammary artery (HMA). Dobutamine produced a maximal positive inotropic effect (+dF/dtmax = 29 ± 7%) at its ED50 for aortic relaxation (88 ± 7 μM). Conversely, at their ED50 for aortic relaxation diltiazem depressed myocardial contractility and amrinone did not exhibit myocardial effects. In HSV and HMA contracted with 80 mM potassium, diltiazem and dobutamine (but not amrinone) had a vasorelaxant activity similar to that in rat aorta. Norepinephrine-contracted human vessels were significantly more sensitive than potassium-contracted vessels to the relaxant effect of amrinone (ED50 HMA = 15 ± 5 μM, ED50 HSV = 72 ± 31 μM, P < 0.05). We conclude that at concentrations still devoid of myocardial effects dobutamine and amrinone are effective dilators in graft segment vessels and rat aorta contracted by membrane depolarization. If the difference between aortic and myocardial tissue still holds in human tissues, at the appropriate concentrations these drugs should be expected to improve cardiac performance while still contributing to the maintenance of graft patency.Facultad de Ciencias Exactas2004info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf893-900http://sedici.unlp.edu.ar/handle/10915/29738enginfo:eu-repo/semantics/altIdentifier/url/http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0100-879X2004000600015&lng=en&nrm=iso&tlng=eninfo:eu-repo/semantics/altIdentifier/issn/0100-879Xinfo:eu-repo/semantics/altIdentifier/pmid/15264033info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc/3.0/Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-17T09:40:28Zoai:sedici.unlp.edu.ar:10915/29738Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-17 09:40:28.305SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
title Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
spellingShingle Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
Gómez Alvis, Alicia
Ciencias Exactas
Biología
Amrinona
Dobutamina
Diltiazem
Vena Safena
Arterias Mamarias
title_short Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
title_full Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
title_fullStr Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
title_full_unstemmed Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
title_sort Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization
dc.creator.none.fl_str_mv Gómez Alvis, Alicia
Rebolledo, Alejandro
Milesi, Verónica
Raingo, Jesica
Sanz, Nora
Tommasi, Juan J.
Drago, Adolfo
Rinaldi, Gustavo
Grassi de Gende, Ángela
author Gómez Alvis, Alicia
author_facet Gómez Alvis, Alicia
Rebolledo, Alejandro
Milesi, Verónica
Raingo, Jesica
Sanz, Nora
Tommasi, Juan J.
Drago, Adolfo
Rinaldi, Gustavo
Grassi de Gende, Ángela
author_role author
author2 Rebolledo, Alejandro
Milesi, Verónica
Raingo, Jesica
Sanz, Nora
Tommasi, Juan J.
Drago, Adolfo
Rinaldi, Gustavo
Grassi de Gende, Ángela
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Ciencias Exactas
Biología
Amrinona
Dobutamina
Diltiazem
Vena Safena
Arterias Mamarias
topic Ciencias Exactas
Biología
Amrinona
Dobutamina
Diltiazem
Vena Safena
Arterias Mamarias
dc.description.none.fl_txt_mv Hemodynamic care during postoperative management of myocardial revascularization should include vasorelaxing drugs to insure adequate graft and coronary flow, and stimulation of stroke volume to maintain vascular perfusion pressure. We tested the cardiac (inotropic and lusitropic) and vascular (relaxant) effects of diltiazem (0.1 nM to 0.1 mM), dobutamine (10 μM to 10 mM) and amrinone (10 μM to 1 mM) on isolated rat atria and thoracic aorta, and also on isolated human saphenous vein (HSV) and human mammary artery (HMA). Dobutamine produced a maximal positive inotropic effect (+dF/dtmax = 29 ± 7%) at its ED50 for aortic relaxation (88 ± 7 μM). Conversely, at their ED50 for aortic relaxation diltiazem depressed myocardial contractility and amrinone did not exhibit myocardial effects. In HSV and HMA contracted with 80 mM potassium, diltiazem and dobutamine (but not amrinone) had a vasorelaxant activity similar to that in rat aorta. Norepinephrine-contracted human vessels were significantly more sensitive than potassium-contracted vessels to the relaxant effect of amrinone (ED50 HMA = 15 ± 5 μM, ED50 HSV = 72 ± 31 μM, P < 0.05). We conclude that at concentrations still devoid of myocardial effects dobutamine and amrinone are effective dilators in graft segment vessels and rat aorta contracted by membrane depolarization. If the difference between aortic and myocardial tissue still holds in human tissues, at the appropriate concentrations these drugs should be expected to improve cardiac performance while still contributing to the maintenance of graft patency.
Facultad de Ciencias Exactas
description Hemodynamic care during postoperative management of myocardial revascularization should include vasorelaxing drugs to insure adequate graft and coronary flow, and stimulation of stroke volume to maintain vascular perfusion pressure. We tested the cardiac (inotropic and lusitropic) and vascular (relaxant) effects of diltiazem (0.1 nM to 0.1 mM), dobutamine (10 μM to 10 mM) and amrinone (10 μM to 1 mM) on isolated rat atria and thoracic aorta, and also on isolated human saphenous vein (HSV) and human mammary artery (HMA). Dobutamine produced a maximal positive inotropic effect (+dF/dtmax = 29 ± 7%) at its ED50 for aortic relaxation (88 ± 7 μM). Conversely, at their ED50 for aortic relaxation diltiazem depressed myocardial contractility and amrinone did not exhibit myocardial effects. In HSV and HMA contracted with 80 mM potassium, diltiazem and dobutamine (but not amrinone) had a vasorelaxant activity similar to that in rat aorta. Norepinephrine-contracted human vessels were significantly more sensitive than potassium-contracted vessels to the relaxant effect of amrinone (ED50 HMA = 15 ± 5 μM, ED50 HSV = 72 ± 31 μM, P < 0.05). We conclude that at concentrations still devoid of myocardial effects dobutamine and amrinone are effective dilators in graft segment vessels and rat aorta contracted by membrane depolarization. If the difference between aortic and myocardial tissue still holds in human tissues, at the appropriate concentrations these drugs should be expected to improve cardiac performance while still contributing to the maintenance of graft patency.
publishDate 2004
dc.date.none.fl_str_mv 2004
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/29738
url http://sedici.unlp.edu.ar/handle/10915/29738
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0100-879X2004000600015&lng=en&nrm=iso&tlng=en
info:eu-repo/semantics/altIdentifier/issn/0100-879X
info:eu-repo/semantics/altIdentifier/pmid/15264033
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc/3.0/
Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc/3.0/
Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)
dc.format.none.fl_str_mv application/pdf
893-900
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1843532089014616064
score 13.001348